Micron Is Up Sharply This Year. The Biggest Quarter Hasn’t Landed Yet.
Monetary Elite HBM is sold out through 2026. The valuation debate is just getting started.
Broadcom Just Locked In Apple Until 2031. The Real Deal Is Not the iPhone.
An ASIC partnership extension just turned into an AI server story nobody is fully pricing.
Nike Is Down 45% From Its Peak. The Brand Is Still There.
The turnaround is real but slow. China is the problem nobody has solved yet.
Broadcom Is Down 27% From Its High. The AI Story Hasn’t Changed.
A selloff built on unmet expectations may be the most interesting entry point in the chip space right now.
Oil Just Fell Back to Pre-War Levels. The Real Trade Is Not Energy Stocks.
Crude is back near $68. The second-order beneficiaries of that collapse are hiding in plain sight.
GOOGL Reports July 22. The Stock Is Down About 10% From Its Post–Q1 Peak—and the Antitrust Risk Still Isn’t Cleanly Priced.
A ~$460B cloud backlog is real. So is a remedies decision that could reshape Google’s search and ad economics.
Big Pharma Has $1.3 Trillion to Spend. The Clock Is Running.
A patent cliff with a known deadline is forcing the largest acquisition wave in biopharma history.
SanDisk Is Down 15% This Week. BofA Just Raised Its Target to $2,500.
The AI memory shortage that drove a 700% gain is still intact. The pullback is the story.
SpaceX Is Now Public. The Real Question Starts Now.
SPCX went public at $135 and hit $225 in four days. Now it's back near $157. So what is this…
Broadcom Is Down 25% From Its High. The AI Numbers Say Something Different.
Custom chip revenue just grew 143% year over year. The selloff may be the opportunity.